New strategies against drug resistance to herpes simplex virus
YC Jiang, H Feng, YC Lin, XR Guo - International journal of oral …, 2016 - nature.com
Herpes simplex virus (HSV), a member of the Herpesviridae family, is a significant human
pathogen that results in mucocutaneous lesions in the oral cavity or genital infections …
pathogen that results in mucocutaneous lesions in the oral cavity or genital infections …
Lethal mutagenesis of RNA viruses and approved drugs with antiviral mutagenic activity
I Hadj Hassine, M Ben M'hadheb, L Menéndez-Arias - Viruses, 2022 - mdpi.com
In RNA viruses, a small increase in their mutation rates can be sufficient to exceed their
threshold of viability. Lethal mutagenesis is a therapeutic strategy based on the use of …
threshold of viability. Lethal mutagenesis is a therapeutic strategy based on the use of …
[HTML][HTML] Lethal mutagenesis of RNA viruses and approved drugs with antiviral mutagenic activity
IH Hassine, MB M'hadheb, L Menéndez-Arias - Viruses, 2022 - ncbi.nlm.nih.gov
In RNA viruses, a small increase in their mutation rates can be sufficient to exceed their
threshold of viability. Lethal mutagenesis is a therapeutic strategy based on the use of …
threshold of viability. Lethal mutagenesis is a therapeutic strategy based on the use of …
Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses
Enteroviruses are major causative agents of various human diseases, and some of them are
currently considered to be an enormous threat to public health. However, no effective …
currently considered to be an enormous threat to public health. However, no effective …
[HTML][HTML] Selected nucleos (t) ide-based prescribed drugs and their multi-target activity
Nucleos (t) ide analogues play pivotal roles as antiviral, cytotoxic or immunosuppressive
agents. Here, we review recent reports of nucleoside analogues that exhibit broad-spectrum …
agents. Here, we review recent reports of nucleoside analogues that exhibit broad-spectrum …
Fitness-dependent, mild mutagenic activity of Sofosbuvir for hepatitis C virus
B Martínez-González, I Gallego, J Gregori… - Antimicrobial Agents …, 2023 - Am Soc Microbiol
The concept of a mild mutagen was coined to describe a minor mutagenic activity exhibited
by some nucleoside analogues that potentiated their efficacy as antiretroviral agents. In the …
by some nucleoside analogues that potentiated their efficacy as antiretroviral agents. In the …
Resveratrol, sirtuins, and viruses
T Yang, S Li, X Zhang, X Pang, Q Lin… - Reviews in medical …, 2015 - Wiley Online Library
Resveratrol is a natural phenolic product found in some plants in response to stress and has
been linked to the many health benefits of red wine. Over the past several decades, a great …
been linked to the many health benefits of red wine. Over the past several decades, a great …
HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation
JMO Rawson, SR Landman, CS Reilly, LM Mansky - Retrovirology, 2015 - Springer
Background Human immunodeficiency virus type 2 (HIV-2) is often distinguished clinically
by lower viral loads, reduced transmissibility, and longer asymptomatic periods than for …
by lower viral loads, reduced transmissibility, and longer asymptomatic periods than for …
Molecular Biology and Diversification of Human Retroviruses
ME Meissner, N Talledge, LM Mansky - Frontiers in virology, 2022 - frontiersin.org
Studies of retroviruses have led to many extraordinary discoveries that have advanced our
understanding of not only human diseases, but also molecular biology as a whole. The most …
understanding of not only human diseases, but also molecular biology as a whole. The most …
Novel inhibitors of human immunodeficiency virus type 2 infectivity
LB Beach, JM Rawson, B Kim… - Journal of General …, 2014 - microbiologyresearch.org
Human immunodeficiency virus type 2 (HIV-2) infects about two million people worldwide.
HIV-2 has fewer treatment options than HIV-1, yet may evolve drug resistance more quickly …
HIV-2 has fewer treatment options than HIV-1, yet may evolve drug resistance more quickly …